325 related articles for article (PubMed ID: 16875900)
1. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation.
Anand K; Mooss AN; Hee TT; Mohiuddin SM
Am Heart J; 2006 Aug; 152(2):217-22. PubMed ID: 16875900
[TBL] [Abstract][Full Text] [Related]
2. The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
Zhang Y; Zhang P; Mu Y; Gao M; Wang JR; Wang Y; Su LQ; Hou YL
Clin Pharmacol Ther; 2010 Oct; 88(4):521-31. PubMed ID: 20811347
[TBL] [Abstract][Full Text] [Related]
3. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials).
Andraws R; Brown DL
Am J Cardiol; 2007 Apr; 99(7):1006-12. PubMed ID: 17398202
[TBL] [Abstract][Full Text] [Related]
4. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
Kalus JS; Coleman CI; White CM
J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
[TBL] [Abstract][Full Text] [Related]
5. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E
Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613
[TBL] [Abstract][Full Text] [Related]
6. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
7. [Upstream therapy of atrial fibrillation in patients with heart failure].
Alboni P; Gianfranchi L; Pacchioni F
G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials, the renin angiotensin system and atrial fibrillation.
Birnie DH; Gollob M; Healey JS
Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
[TBL] [Abstract][Full Text] [Related]
9. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
Doğan A; Akçay S
Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
Lip GY; Frison L; Grind M
J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
Zografos T; Katritsis DG
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
[TBL] [Abstract][Full Text] [Related]
12. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
Healey JS; Morillo CA; Connolly SJ
Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
[TBL] [Abstract][Full Text] [Related]
13. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
14. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
[TBL] [Abstract][Full Text] [Related]
15. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
Lévy S
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.
Baker WL; White CM
Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005
[No Abstract] [Full Text] [Related]
17. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
[TBL] [Abstract][Full Text] [Related]
18. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
19. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
Ducharme A; Schiffrin EL
Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease.
Singh JP; Kulik A; Levin R; Ellinor PT; Ruskin J; Avorn J; Choudhry NK
Europace; 2012 Sep; 14(9):1287-93. PubMed ID: 22539600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
